Alternative asset management firm, BluePeak Private Capital, has announced an investment of up to US$15m in Africure, a pan-African manufacturer and distributor of pharmaceutical goods. The investment provides a vital working capital boost to Africure as it faces increased demand for pharmaceutical goods across its more than 10 African markets. Founded in 2017, Africure Pharmceutical,…
Home Healthcare Markets International News Africa: BluePeak impact investment of up to US$15m supports Africure’s Africa strategy